Alimera Sciences, Inc. (ALIM)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.59+0.00 (+0.32%)
As of 11:18 AM EDT. Market open.
People also watch:
PSDVACRXANTHAEGREVOK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.58
Prev Close1.58
Bid1.58 x 2700
Ask1.59 x 26000
Day's Range1.56 - 1.59
52wk Range1.01 - 5.15
1y Target EstN/A
Market Cap100.45M
P/E Ratio (ttm)-2.34
Beta2.21
Volume96,074
Avg Vol (3m)942,968
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake
    Insider Monkey6 days ago

    Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake

    Jeffrey Jay and David Kroin‘s Great Point Partners reported the acquisition of 3.25 million common shares of Alimera Sciences Inc (NASDAQ:ALIM) which account for 5.12% of the company’s outstanding stock, via a recent 13G filing with the SEC. The acquisition represents a new addition to Great Point Partners’ portfolio. Alimera Sciences is a pharmaceutical company that works […]

  • GlobeNewswire13 days ago

    Alimera Sciences Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $26.5 Million Offering of Common Stock

    ATLANTA, Aug. 16, 2016-- Alimera Sciences, Inc., a pharmaceutical company that specializes in research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ...

  • Capital Cube17 days ago

    ETF’s with exposure to Alimera Sciences, Inc. : August 12, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Alimera Sciences, Inc. Here are 5 ETF’s with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)